Applied Therapeutics, Inc. (APLT) Misses Q3 EPS by 23c

Applied Therapeutics, Inc. (NASDAQ: APLT) reported Q3 EPS of ($0.47), $0.23 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Applied Therapeutics, Inc. (APLT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Paramount Global (PARA) Tops Q2 EPS by 175c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c